These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 425758)

  • 1. [Correlation between brain lesion lateralization and immunologic indices in a model of experimental allergic encephalomyelitis].
    Abramchik GV; Ermakova SS; Tanina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):153-9. PubMed ID: 425758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Asymmetry of brain lesions and immunobiologic reactivity].
    Semenov SF; Chuprikov AP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(12):1798-1806. PubMed ID: 1217363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The temporal relationship of complement-fixing antibrain and tuberculin type sensitivity in experimental allergic encephalomyelitis.
    Greifenkamp J; Bartel AH; Fahlberg WJ
    Ann Allergy; 1970 Nov; 28(11):522-7. PubMed ID: 5521183
    [No Abstract]   [Full Text] [Related]  

  • 4. [Suppression of experimental allergic encephalomyelitis with vaccinia-virus-induced anti-brain antibodies (author's transl)].
    Simon J; Hochstein-Mintzel V; Huber HC; Gradl A; Hansert E
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):23-35. PubMed ID: 68632
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics of chronic experimental allergic encephalomyelitis (immunologic and electron microscopic studies)].
    Davydova GS; Pashkovskaia MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(7):994-1002. PubMed ID: 4777970
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
    Zhitnukhin IuL; Khizhniak MG
    Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive transfer studies in experimental allergic encephalomyelitis.
    Rauch HC; Griffin J
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:387-400. PubMed ID: 5373036
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic unresponsiveness, immunity and enhancement in experimental allergic encephalomyelitis.
    Salvin SB; Liauw HL
    J Immunol; 1968 Jul; 101(1):33-42. PubMed ID: 4173936
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoluminescent study of the sera of guinea pigs with experimental allergic encephalomyelitis].
    Zhitnukhin IuL; Zubzhitskiĭ IuN
    Biull Eksp Biol Med; 1972 Aug; 73(8):63-5. PubMed ID: 4564367
    [No Abstract]   [Full Text] [Related]  

  • 10. Transformation of lymphocytes from monkeys with experimental allergic encephalomyelitis.
    Chaparas SD; Clark RG; Kies MW; Hedrick SR
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):637-52. PubMed ID: 5002788
    [No Abstract]   [Full Text] [Related]  

  • 11. [Passive transmission of experimental allergic encephalomyelitis by serum anti-brain antibodies].
    Vilkov GA; Mezhova LI
    Biull Eksp Biol Med; 1974 Nov; 78(11):76-9. PubMed ID: 4141270
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blastoid transformation of the lymphocytes from experimental allergic encephalomyelitis guinea pigs.
    Nakano K; Nagai Y; Otani S; Tsumita T
    Jpn J Exp Med; 1971 Apr; 41(2):159-62. PubMed ID: 5313764
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development of immunological tolerance to brain antigens as a means of specific prevention and treatment of experimental allergic encephalomyelitis].
    Reber NV
    Biull Eksp Biol Med; 1971 Nov; 72(11):69-73. PubMed ID: 5131039
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental allergic encephalitogenic substance].
    Yonezawa T; Ishihara Y; Nakatani Y; Iizuka R; Mori T
    Shinkei Kenkyu No Shimpo; 1969 Jun; 13(2):346-54. PubMed ID: 5390678
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental allergic encephalomyelitis, a model of demyelination in central nervous system (CNS).
    Gambi D; Onofrj M; Di Trapani G
    Riv Neurol; 1987; 57(1):27-32. PubMed ID: 3629126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomorphologic features of experimental allergic encephalomyelitis induced by the administration of tryptophan peptide].
    Zhitnukhin IuL; Khizhniak MG
    Biull Eksp Biol Med; 1989 Aug; 108(8):241-4. PubMed ID: 2478215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of experimental allergic encephalomyelitis caused by sensitization with Bordetella pertussis combined with cerebral tissue].
    Kanchurin AKh; Kapitonova ME
    Biull Eksp Biol Med; 1971 Sep; 72(9):73-7. PubMed ID: 4329604
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention and depression of experimental allergic encephalomyelitis by the administration of brain antigens and barbamyl].
    Reber NV
    Patol Fiziol Eksp Ter; 1973; 17(1):65-7. PubMed ID: 4127854
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic response to altered encephalitogenic protein in guinea pigs.
    Swanborg RH
    J Immunol; 1969 Feb; 102(2):381-8. PubMed ID: 5765039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.